The Role of Hepatocyte Growth Factor/c-met Interactions in the Immune System

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 5, 2003, Pages 277-282

  Skibinski, Grzegorz ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

c met; Hepatocyte growth factor; Immune system cell functions

Indexed keywords

PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; B LYMPHOCYTE; DENDRITIC CELL; IMMUNE SYSTEM; MACROPHAGE; MONOCYTE; NEUTROPHIL; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE;

ANIMALS; BURKITT LYMPHOMA; DENDRITIC CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNE SYSTEM; LYMPHOCYTES; MACROPHAGES; MONOCYTES; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 0242571955     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. ADAMS D. H., HARVATH L., BOTTARO D. P., INTERRANTE R., CATALANO G., TANAKA Y., STRAIN A., HUBSCHER S. G. and SHAW S. (1994): Hepatocyte growth factor and macrophage inflammatory protein 1b: structurally distinct cytokines that induce rapid cytoskeletal changes and subset preferential migration in T cells. Proc. Natl. Acad. Sci. USA, 91, 7144-7148.
2. BEILMANN M., VANDE WOUDE G. F., DIENES H.-P. and SCHIRMACHER P. (2000): Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood, 15, 3964-3969.
3. BERDICHEVSKI F., ALFORD D., SOUZA B. and TAYLOR-PAPADIMITRIOU J. (1994): Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci., 107, 3557-3568.
4. BORSET M., SEIDEL C., HJORTH-HANSEN H., WAAGE A. and SUNDAN A. (1999): The role of hepatocyte growth factor and its receptor c-Met in multiple myeloma and other blood malignancies. Leuk. Lymphoma, 32, 49-56.
5. BOTTARO D. P., RUBIN J. S., FALETTO D. L., CHAN A. M., KMIECIK T. E., VANDE WOUDE G. F. and AARONSON G. A. (1991): Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science, 251, 802-804.
6. BRINKMANN V., FOROUTAN H., SACHS H., WEIDNER K. M. and BIRCHMEIRE W. (1995): Hepatocyte growth factor/scatter factor induces a variety of tissue specific morphogenetic programs in epithelial cells. J. Cell Sci., 131, 1573-1586.
7. DELANEY B., KOH W. S., YANG K. H., STROM S. C. and KAMINSKI N. Y. (1993): Hepatocyte growth factor enhances B cell activity. Life Sci., 53, PL89-93.
8. DI NICOLA M., CARLO-STELLA C., MAGNI M., MILANESI M., LONGOLI P. D., MATTEUCCI P., GRISANTI S. and GIANNI A. M. (2002): Human bone marrow stromal cells suppress T lymphocyte proliferation induced by cellular or non-specific mitogenic stimuli. Blood, 99, 3838-3843.
9. FURGE K. A., ZHANG Y. W. and VANDE WOUDE G. F. (2000): Met receptor tyrosine kinase: enhanced signalling through adapter proteins. Oncogene, 19, 5582-5592.
10. GALIMI F., COTTONE E., VIGNA E., ARENA N., BOCCACCIO C., GIORDANO S., NALDINI L. and COMOGLIO P. M. (2001): Hepatocyte growth factor is a regulator of monocyte-macrophage function. J. Immunol., 166, 1241-1247.
11. GAUDINO G., FOLLENZI A., NALDINI L., COLLESSI C., SANTORO M., GALLO K. A., GODOWSKI P. J. and COMOGLIO P. M. (1994): RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J., 13, 3524-3532.
12. GIORDANO S., DI RENZO M. F., NARSIHAN R. P., COOPER C. S., ROSA C. and COMOGLIO P. M. (1989): Biosynthesis of the protein encoded by c-met proto-oncogene. Oncogene, 4, 1383-1388.
13. GIORDANO S., PONZETTO C., DI RENZO M. F., COOPER C. S. and COMOGLIO P. M. (1989): Tyrosine kinase receptor indistinguishable from the c-met protein. Nature, 339, 155-157.
14. JAFFRE S., DEHOUX M., PAUGAM C., GRENIER A., CHOLLET-MARTIN S., STERN J.-B., MANTZ J., AUBIER M. and CRESTANI B. (2002): Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. Am. J. Physiol. Lung Cell. Mol. Physil., 282, L310-315.
15. KURZ S. M., DIEBOLD S. S., HIERONYMUS T., GUST T. C., BARTUNEK P., SACHS M., BIRCHMEIR W. and ZENKE M. (2002): The impact of c-met/scatter factor receptor on dendritic cell migration. Eur. J. Immunol., 32, 1832-1838.
16. MICHALOPOULOS G., HOUCK K. A., DOLAN M. L. and LEUTTEKE N. C. (1984): Control of hepatocyte replication by two serum factors. Cancer Res., 44, 4114-4119.
17. MINE S., TANAKA Y., SUEMATU M., ASO M., FUJISAKI T., YAMADA S. and ETO S. (1998): Hepatocyte frowth factor is a potent trigger of neutrohil adhesion through rapid activation of lymphocyte function-associated antigen. Lab. Invest., 78, 1395-1404.
18. NAKA D., ISHII T., YOSHIYAMA Y., MIYAZAWA K., HARA H., HISHIDA T. and KIDAMURA N. (1992): Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J. Biol. Chem., 267, 20114-20119.
19. NAKAMURA T., NAWA K. and ICHIHARA A. (1984): Partial puri-fication and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun., 122, 1450-1459.
20. NAKAMURA T., NISHIZAWA T., HAGIYA M., SEKI T., SHIMONISHI M., SUGIMURA A., TASHIRO K. and SHIMIZU S. (1989): Molecular cloning and expression of human hepatocyte growth factor. Nature, 342, 440-442.
21. PONZETTO C., BARDELLI A., ZHEN Z., MAINE E., DALLA ZONCA P., GIORDANO S., GRAZIANI A., PANAYOTOU G. and COMOGLIO P. M. (1994): A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell, 77, 261-271.
22. RUBIN J. S., DAY R. M., BRECKENRIDGE D., ATABEY N., TAYLOR W. G., STAHL S. J., WINGFIELD P. T., KAUFMAN J. D., SCHWALL R. and BOTTARO D. P. (2001): Dissociation of heparin sulphate and receptor binding domains of hepatocyte growth factor reveals that heparin sulphate-c-met interactions facilitates signalling. J. Biol. Chem., 276, 32977-32983.
23. SAKAI T., SATOH K., MATSUSHIMA K., SHINDO S., ABE S., ABE T., MOTOMIYA M., KAWAMOTO T., KAWABATA Y., NAKAMURA T. and NUKIWA T. (1997): Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by IRA and in situ hybridisation. Am. J. Respir. Cell Mol. Biol., 16, 388-397.
24. SEKI T., HAGIYA T., SHIMONISHI T., NAKAMURA T. and SHIMIZU S. (1991): Organisation of the human hepatocyte growth factor-encoding gene. Gene, 102, 213-219.
25. SKIBINSKI G., SKIBINSKA A. and JAMES K. (2001): The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunology, 102, 506-514.
26. SKIBINSKI G., SKIBINSKA A. and JAMES K. (2001): Hepatocyte growth factor (HGF) protects c-met-expressing Burkitt's lymphoma cell lines from apoptotic death induced by DNA damaging agents. Eur. J. Cancer, 37, 1562-1569.
27. SKIBINSKI G., SKIBINSKA A., STEWART G. D. and JAMES K. (1998): Enhancement of terminal B lymphocytes differentiation in vitro by fibroblast-like stromal cells from human spleen. Eur. J. Immunol., 29, 3940-3948.
28. STERN J. B., FIEROBE L., PAUGAM C., ROLLAND C., DEHOUX M., PETIET A., DOMBRET M. C., MANTZ J., AUBIER M. and CRESTANI B. (2000): Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluids in ARDS patients. Crit. Care Med., 28, 2326-2803.
29. TAKAI K., HARA J., MATSUSMOTO K., HOSOI G., OSUGI Y., TAWA A., OKADA S. and NAKAMURA T. (1997): Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. Blood, 89, 1560-1565.
30. TAMURA S., SUGAWARA T., TOKORO Y., TANIGUCHI H., FUKAO K., NAKAUCHI H. and TAKAHAMA Y. (1998): Expression and function of c-Met a receptor for hepatocyte growth factor, during T cell development. Scand. J. Immunol., 47, 296-301.
31. UEHARA Y., MINOWA O., MORI C., SHIOTA K., KUNO J., NODA T. and KITAMURA N. (1995): Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature, 373, 702-705.
32. VAN DER VOORT R., TAHER E. I., KEEHNEN R. M. J., SMIT L., GROENINK M. and PALS S. T. (1997): Paracrine regulation of germinal center B cell adhesion through c-met hepatocyte growth factor/scatter factor pathway J. Exp. Med., 185, 2121-2131.
33. VAN DER VOORT R., TAHER E. I., WIELENGA V. J. M., SPAARGAREN M., PREVO R., SMIT L., DAVID G., HARTMANN G., GHERARDI E. and PALS S. (1999): Heparan sulphate modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-met. J. Biol. Chem., 274, 6499-6506.
34. WEIMAR I. S., DE JONG D., MULLER E. J., NAKAMURA T. and VAN GORP J. M. H. H. (1997): Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via a4b1 and a5b1 integrins. Blood, 89, 990-1000.
35. ZARNEGAR R. and MICHALOPOULOS G. K. (1995): The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell. Biol., 129, 1177-1182.